Colloidal silver is a suspension of silver nanoparticles in ultrapure water, generally produced by electrolysis. Its concentration is expressed in ppm (parts per million), and it is precisely the particle size, combined with the ppm level, that determines how the particles interact with biological tissues.
Particle size and ionic charge: what sets colloidal silver apart from ionic silver
Confusion between colloidal silver and ionic silver remains the market’s biggest blind spot. A genuine colloidal product contains a majority of suspended metallic silver nanoparticles, kept in suspension by the Tyndall effect. An ionic product, by contrast, releases dissolved Ag+ ions, which are more chemically reactive but also less stable in a biological environment.
Particle size determines the exchange surface area. The smaller the particle, the greater its relative surface area and the more pronounced its interaction with cell membranes. Commercial products rarely disclose particle size. A bottle labelled “20 ppm” may contain mostly ions, mostly particles, or a mixture of both, which users cannot verify without spectrophotometry.
In practice, a quality colloidal solution has a characteristic pale yellow tint (surface plasmon resonance). A perfectly clear solution often indicates a predominantly ionic composition. While this visual test is only approximate, it offers an initial indication of the product’s true nature.
Documented topical uses and the clinical limitations of silver
Silver has been used on the skin for centuries. In modern medicine, silver is incorporated into certain wound dressings classified as medical devices, intended for wounds showing signs of local infection. These dressings are not equivalent to bottled colloidal silver.
A 2022 Cochrane review of 26 randomised trials involving more than 2,000 participants concluded that the evidence was insufficient to establish that silver dressings speed up healing or prevent infection. It also noted that silver sulfadiazine could slow the healing of superficial burns.
For more information on the uses of colloidal silver for external application, the distinction between traditional use and clinical evidence remains key. Applying it to minor skin irritations, using it as a nasal spray or as a low-concentration mouthwash are the most common uses, although they are not supported by high-quality clinical trials.
Regulatory framework in France and the European Union
Colloidal silver is not classified as a medicine, food supplement or antiseptic in France. It is marketed as a cosmetic product or “hygiene solution”, which strictly limits the claims that can be made about it.
In the United States, health authorities consider that products containing colloidal silver lack sufficient evidence to be marketed as over-the-counter medicines.
In Europe, cosmetics regulations govern silver nanoparticles, and any product containing nanomaterials must state this on its label. This regulatory grey area between cosmetics and healthcare products fuels the circulation of products with unverified claims.
Concentration and format: practical guidelines
- 5 ppm: daily use as a nasal or skin hygiene spray; suitable for sensitive skin. Low reactivity and high tolerability.
- 15 to 20 ppm: versatile concentration for occasional topical use (irritation, minor skin lesions). This is the most common strength on the market.
- 40 ppm and above: localised, short-term use. At these concentrations, the risk of local irritation increases, and no evidence shows any benefit over 20 ppm.
Real risks: argyria, liver toxicity and disruption of the microbiome
Prolonged ingestion of colloidal silver carries a risk of argyria, an irreversible blue-grey discolouration of the skin. This deposit of silver sulfide in the dermis is permanent and has no known treatment. Documented cases involve daily consumption over several months.
Beyond argyria, the accumulation of silver in the body raises questions about possible effects on the liver and kidneys, although human data remain limited. These uncertainties reinforce the recommendation to restrict use to external application.
Contraindications and interactions to be aware of
- Pregnant and breastfeeding women: no safety data are available; use is not recommended as a precaution.
- Patients taking antibiotics: seek medical advice before using them together.
- Liver or kidney conditions: reduced ability to eliminate silver increases the risk of accumulation.
- Young children: immature elimination pathways make it advisable to avoid all use, including prolonged topical use.
Colloidal silver remains a product at the crossroads of tradition, marketing and regulation. Low-concentration topical use for short periods is the only reasonably well-documented context for its use. Regular ingestion has no solid clinical basis and carries cumulative risks. Given the wide variation in products available, checking the solution’s true nature (colloidal or ionic), its concentration and its regulatory labelling is the bare minimum before use.
